Premature deaths due to noncommunicable diseases (NCD) as a in South-East Asia (WHO region)
South-East Asia (WHO region): Premature deaths due to noncommunicable diseases (NCD) as a was 53.14 in 2021. ▼ Falling
Premature deaths due to noncommunicable diseases (NCD) as a in South-East Asia (WHO region), 2000–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, premature deaths due to noncommunicable diseases (ncd) as a in South-East Asia (WHO region) stood at 53.14.
Compared with earlier readings it is up 1.5% on the previous year and down 4.7% over ten years.
Over the whole period, premature deaths due to noncommunicable diseases (ncd) as a in South-East Asia (WHO region) peaked at 61.97 in 2000 and was at its lowest, 52.36, in 2020.
The long-run direction has been consistently falling across the 22 years of available data.
Premature deaths due to noncommunicable diseases (NCD) as a in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 61.97 | — |
| 2001 | 61.18 | -1.3% |
| 2002 | 60.56 | -1.0% |
| 2003 | 59.19 | -2.3% |
| 2004 | 57.96 | -2.1% |
| 2005 | 57.66 | -0.5% |
| 2006 | 57.09 | -1.0% |
| 2007 | 56.11 | -1.7% |
| 2008 | 55.65 | -0.8% |
| 2009 | 55.82 | +0.3% |
| 2010 | 55.99 | +0.3% |
| 2011 | 55.73 | -0.5% |
| 2012 | 55.51 | -0.4% |
| 2013 | 53.99 | -2.8% |
| 2014 | 52.79 | -2.2% |
| 2015 | 53.48 | +1.3% |
| 2016 | 53.65 | +0.3% |
| 2017 | 53.46 | -0.3% |
| 2018 | 53.53 | +0.1% |
| 2019 | 53.22 | -0.6% |
| 2020 | 52.36 | -1.6% |
| 2021 | 53.14 | +1.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 58.32 | 55.65 | 61.97 | 10 |
| 2010s | 54.14 | 52.79 | 55.99 | 10 |
| 2020s | 52.75 | 52.36 | 53.14 | 2 |
Countries ranked near South-East Asia (WHO region)
More health data for South-East Asia (WHO region)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is premature deaths due to noncommunicable diseases (ncd) as a in South-East Asia (WHO region)?
- Premature deaths due to noncommunicable diseases (ncd) as a in South-East Asia (WHO region) was 53.14 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest premature deaths due to noncommunicable diseases (ncd) as a recorded in South-East Asia (WHO region)?
- The highest recorded value was 61.97 in 2000.
- What is the lowest premature deaths due to noncommunicable diseases (ncd) as a recorded in South-East Asia (WHO region)?
- The lowest recorded value was 52.36 in 2020.
- How does South-East Asia (WHO region) rank for premature deaths due to noncommunicable diseases (ncd) as a?
- South-East Asia (WHO region) ranks 5th out of 11 groups with data for 2021.
- Is premature deaths due to noncommunicable diseases (ncd) as a rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is down 4.7%. The long-run trend across the full record is falling.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).